Blue fog: Citalopram, methylene blue, serotonin syndrome

Toby N. Weingarten, Wayne T. Nicholson, Juraj Sprung

Research output: Chapter in Book/Report/Conference proceedingChapter


This case discusses a pharmacodynamics interaction between citalopram and methylene blue, resulting in serotonin syndrome. Citalopram is a selective serotonin reuptake inhibitor and methylene blue is a reversible monoamine oxidase inhibitor.

Original languageEnglish (US)
Title of host publicationA Case Approach to Perioperative Drug-Drug Interactions
PublisherSpringer New York
Number of pages5
ISBN (Electronic)9781461474951
ISBN (Print)9781461474944
StatePublished - Sep 15 2015

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Blue fog: Citalopram, methylene blue, serotonin syndrome'. Together they form a unique fingerprint.

Cite this